These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 25662955

  • 21. COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer.
    Kim G, Khanal P, Kim JY, Yun HJ, Lim SC, Shim JH, Choi HS.
    Mol Carcinog; 2015 Jun; 54(6):440-8. PubMed ID: 24265246
    [Abstract] [Full Text] [Related]

  • 22. [Recent advances in the study of pin1 and its inhibitors].
    Zhang CJ, Zhang ZH, Xu BL, Wang YL.
    Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
    [Abstract] [Full Text] [Related]

  • 23. Pin1: Intimate involvement with the regulatory protein kinase networks in the global phosphorylation landscape.
    Litchfield DW, Shilton BH, Brandl CJ, Gyenis L.
    Biochim Biophys Acta; 2015 Oct; 1850(10):2077-86. PubMed ID: 25766872
    [Abstract] [Full Text] [Related]

  • 24. Pin1 acts as a modulator of cell proliferation through alteration in NF-κB but not β-catenin/TCF4 signalling in a subset of endometrial carcinoma cells.
    Saegusa M, Hashimura M, Kuwata T.
    J Pathol; 2010 Dec; 222(4):410-20. PubMed ID: 20922712
    [Abstract] [Full Text] [Related]

  • 25. Multisite phosphorylation of Pin1-associated mitotic phosphoproteins revealed by monoclonal antibodies MPM-2 and CC-3.
    Albert AL, Lavoie SB, Vincent M.
    BMC Cell Biol; 2004 Jun 01; 5():22. PubMed ID: 15171797
    [Abstract] [Full Text] [Related]

  • 26. Pinning down cell signaling, cancer and Alzheimer's disease.
    Lu KP.
    Trends Biochem Sci; 2004 Apr 01; 29(4):200-9. PubMed ID: 15082314
    [Abstract] [Full Text] [Related]

  • 27. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest.
    Fujimori F, Takahashi K, Uchida C, Uchida T.
    Biochem Biophys Res Commun; 1999 Nov 30; 265(3):658-63. PubMed ID: 10600477
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Targeting carcinogenesis: a role for the prolyl isomerase Pin1?
    Lu KP, Suizu F, Zhou XZ, Finn G, Lam P, Wulf G.
    Mol Carcinog; 2006 Jun 30; 45(6):397-402. PubMed ID: 16652378
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Structural Analysis of the Pin1-CPEB1 interaction and its potential role in CPEB1 degradation.
    Schelhorn C, Martín-Malpartida P, Suñol D, Macias MJ.
    Sci Rep; 2015 Oct 12; 5():14990. PubMed ID: 26456073
    [Abstract] [Full Text] [Related]

  • 37. Cudraxanthone H Induces Growth Inhibition and Apoptosis in Oral Cancer Cells via NF-κB and PIN1 Pathways.
    Lee HJ, Jue SS, Kang SK, Bae WJ, Kim YC, Kim EC.
    Am J Chin Med; 2015 Oct 12; 43(7):1439-52. PubMed ID: 26477796
    [Abstract] [Full Text] [Related]

  • 38. Aluminum(III) interferes with the structure and the activity of the peptidyl-prolyl cis-trans isomerase (Pin1): a new mechanism contributing to the pathogenesis of Alzheimer's disease and cancers?
    Wang JZ, Liu J, Lin T, Han YG, Luo Y, Xi L, Du LF.
    J Inorg Biochem; 2013 Sep 12; 126():111-7. PubMed ID: 23806774
    [Abstract] [Full Text] [Related]

  • 39. Pin1 in Alzheimer's disease.
    Butterfield DA, Abdul HM, Opii W, Newman SF, Joshi G, Ansari MA, Sultana R.
    J Neurochem; 2006 Sep 12; 98(6):1697-706. PubMed ID: 16945100
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.